血管加压素启动时机与感染性休克院内死亡率:大型公共数据库的观察性研究
该回顾性观察研究利用MIMIC-IV和eICU-CRD两个数据库,纳入基于改良Sepsis-3标准诊断的成人感染性休克并接受持续 catecholamine 输注的患者,共1409例、来自209家医院。在启动血管加压素时,去甲肾上腺素当量剂量中位数为28.4 µg/min,乳酸为3.7 mmol/L,距休克发生时间为5.6小时。多变量回归显示,启动时去甲肾上腺素当量剂量、乳酸浓度和距休克发生时间均与院内死亡率独立相关。作者结论认为,较早启动辅助性血管加压素可能降低感染性休克患者的死亡率。
要点
- 启动血管加压素时去甲肾上腺素当量剂量为72 µg/min的患者,院内死亡 odds 是9 µg/min患者的3.93倍(校正OR 3.93,95%CI 2.74-5.64)。
- 启动血管加压素时去甲肾上腺素当量剂量为28 µg/min的患者,院内死亡 odds 较9 µg/min患者升高90%(校正OR 1.90,95%CI 1.49-2.41)。
- 启动血管加压素时乳酸每升高1 mmol/L,院内死亡 odds 增加16%(校正OR 1.16,95%CI 1.11-1.21)。
- 距休克发生至启动血管加压素每延迟1小时,院内死亡 odds 增加3%(校正OR 1.03,95%CI 1.01-1.04)。
- 作者结论认为,较早启动辅助性血管加压素可能降低感染性休克患者的死亡率。
适用人群与场景
- 成人感染性休克患者,基于改良Sepsis-3标准诊断,并接受持续 infusion catecholamine 治疗,数据来自MIMIC-IV和eICU-CRD数据库。
诊断标准与关键阈值
- 感染性休克诊断基于改良Sepsis-3标准。
研究设计与关键结果
- 研究类型为回顾性观察性研究,利用MIMIC-IV和eICU-CRD数据库,纳入1409例来自209家医院的成人感染性休克患者。
- 启动血管加压素时,去甲肾上腺素当量剂量中位数28.4 µg/min(四分位距16.4-42.6 µg/min),乳酸3.7 mmol/L(四分位距2.5-6.2 mmol/L),距休克发生时间5.6小时(四分位距2.0-13.5小时)。
- 限制性立方样条识别出3个节点:去甲肾上腺素当量剂量9、28、72 µg/min,在此处去甲肾上腺素当量剂量与院内死亡率的关系发生显著变化。
- 与9 µg/min相比,启动血管加压素时去甲肾上腺素当量剂量28 µg/min的院内死亡校正OR为1.90(95%CI 1.49-2.41),72 µg/min的校正OR为3.93(95%CI 2.74-5.64)。
- 启动血管加压素时乳酸每升高1 mmol/L,院内死亡校正OR为1.16(95%CI 1.11-1.21)。
- 距休克发生至启动血管加压素每延迟1小时,院内死亡校正OR为1.03(95%CI 1.01-1.04)。
证据类型、等级与局限
- 证据类型:回顾性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,较早启动辅助性血管加压素可能降低感染性休克患者的死亡率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Vasopressin is used in one-third of patients with septic shock to augment hemodynamics and reduce overall catecholamine exposure. However, the optimal clinical context in which to initiate vasopressin is unknown.
OBJECTIVES: To determine the association between norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective, observational evaluation utilizing Medical Information Mart for Intensive Care-IV and electronic ICU Collaborative Research Database databases of adult patients with septic shock based on modified Sepsis-3 criteria receiving continuous infusion catecholamines.
MAIN OUTCOMES AND MEASURES: The associations of norepinephrine-equivalent dose, lactate concentration, and time duration from shock onset at vasopressin initiation with in-hospital mortality were evaluated with multivariable regression models.
RESULTS: In total, 1409 patients from 209 hospitals were included. At vasopressin initiation patients had a median (interquartile range) norepinephrine-equivalent dose 28.4 µg/min (16.4-42.6 µg/min), lactate concentration 3.7 mmol/L (2.5-6.2 mmol/L), and 5.6 hours (2.0-13.5 hr) had elapsed since shock onset. All three variables of interest were associated with in-hospital mortality. Three restricted cubic spline knots were identified where the relationship between norepinephrine-equivalent dose and in-hospital mortality changed substantially: 9, 28, and 72 µg/min. The odds of in-hospital mortality increased by 90% and 3.9-fold when comparing vasopressin initiation at norepinephrine-equivalent doses of 28 µg/min and 72 µg/min to 9 µg/min, respectively (adjusted odds ratio [OR], 1.90 [95% CI, 1.49-2.41] and 3.93 [95% CI, 2.74-5.64]). The odds of in-hospital mortality increased by 16% for every mmol/L in the lactate concentration at vasopressin initiation (adjusted OR, 1.16 [95% CI, 1.11-1.21]). Finally, the odds of in-hospital mortality increased by 3% for every hour in the time duration from shock onset to vasopressin initiation (adjusted OR, 1.03 [95% CI, 1.01-1.04]).
CONCLUSIONS AND RELEVANCE: Earlier adjunctive vasopressin initiation may decrease mortality in patients with septic shock.
参考来源
- Sacha GL, Duggal A, Reddy AJ, et al. Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases. Crit Care Explor. 2025. PMID: 40844800. doi:10.1097/CCE.0000000000001284
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。